JNJ

Johnson & Johnson’s Outlook Improving, Steadily Putting Legal Issues Behind It

by

Image Source: Johnson & Johnson – Fourth Quarter of Fiscal 2021 IR Earnings Presentation By Callum Turcan On a price-only basis, shares of Johnson & Johnson (JNJ) are up ~2% year-to-date through the end of regular trading hours on March 22, while the S&P 500 (SPY) is down ~6% during this period. We include shares of Johnson & Johnson as an idea in both the Best Ideas Newsletter and Dividend Growth Newsletter portfolios, and we love the company’s resiliency in the face of whatever challenges are thrown at it. In our view, the relative strength seen in Johnson & Johnson’s stock price is the product of its legal strategies moving things in the right direction and the favorable fiscal 2022 … Read more

Johnson & Johnson’s Pending Split-Up, Talc Liabilities, New CEO Add Complexity to a Once-Clean Dividend Growth Story

by

  Image Shown: J&J continues to face legal liabilities due to talcum powder lawsuits. Image Source: Mike Mozart.  By Brian Nelson, CFA Johnson & Johnson’s (JNJ) dividend growth story has become much more complicated in recent years. On a price-only basis, shares of the consumer and pharma giant haven’t been nearly as impressive as that of technology names, but the company still has put up a nice 45% price-only return the past five years, further bolstered by a continuous stream of quarterly dividend payments. J&J yields ~2.6% at the time of this writing, and the company reluctantly remains the bedrock of the Dividend Growth Newsletter portfolio, at least for now. The Split-Up Before we dig into J&J’s fourth-quarter 2021 results, … Read more

Don’t Throw the Baby Out with the Bathwater

by

Image: Erica Nicol Takeaways: Junk tech should continue to collapse, but the stylistic area of large cap growth and big cap tech should remain resilient. Moderately elevated levels of inflation coupled with interest rates hovering at all-time lows isn’t a terrible combination. In fact, it’s not bad at all. The markets are digesting the huge gains of the past few years so far in 2022, and the excesses in ARKK funds, crypto, SPACs, and meme stocks are being rid from the system. Our best ideas are “outperforming” the very benchmarks that are outperforming everyone else. The BIN portfolio is down 6.4% and the DGN portfolio is down 3.2% year to date. The SPY is down 7.8%, while the average investor … Read more

Valuentum’s Brian Nelson in CFA Institute’s ‘Enterprising Investor’

by

From CFA Institute’s ‘Enterprising Investor’: — By Brian Nelson, CFA — “I couldn’t sleep. I knew something was wrong. The numbers just didn’t make sense. For years, pipeline energy analysts seemed to be adjusting their valuation models for pipeline master limited partnership (MLP) stocks in order to explain what was happening to the price. — But why? Why adjust the models for one set of companies and not for another? Cash is cash and value is the measure of cash going into and out of a business. There aren’t different rules for different companies. Valuation is universal.” — To continue reading >> — —– — About Brian Michael Nelson, CFA Brian Michael Nelson, CFAPresident, Equity Research & ETF AnalysisE-mail: brian@valuentum.com Brian … Read more

Dividend Growth Stocks Soar!

by

Dear members: — We’re watching one of the strongest stock market rallies we’ve seen in some time during the trading session December 7. At the time of this writing, the Dow Jones Industrial Average is up over 500 points, the S&P is up nearly 100, while the NASDAQ is up a tremendous 440+. We continue to like what we see. — Almost every idea in the Best Ideas Newsletter portfolio is up today, led by Chipotle (CMG) +5.9%, PayPal (PYPL) +3.3%, Domino’s (DPZ) +3.1%, Apple (AAPL) +2.9% and Alphabet (GOOG) +2.9%. — We’re loving the moves by Valuentum-style stocks today, and we’re even more excited to report that every idea in the Dividend Growth Newsletter portfolio is advancing today, as shown below. We know … Read more

Valuentum Weekly: Nothing Surprising, Well-Positioned!

by

Image source: Cathie Wood’s flagship ETF, the ARK Innovation ETF (ARKK) has fallen more more than 40% from its 52-week high. This is nothing short of a complete and utter bloodbath for such an actively-managed fund, in our view. We note this for context. We’re not just talking about one or two or five stocks that are down 40% from 52-week highs, but the *entire fund.* Investors have to keep things in perspective. It’s perfectly reasonable within the context of a portfolio to have a few stocks off 10%, 20%, or maybe even 50% from all-time highs. However, if your entire portfolio is down 40%+ from 52-week highs, you’re doing something wrong. Hi everyone: It’s the most wonderful time of … Read more

Asset Allocators Fail, Advisors Should Pick Stocks, Save Investors $34 Billion Annually

by

  Image: The area of large cap growth has trounced that of the 60/40 stock/bond portfolio for more than a decade. Image Source: Morningstar. By Brian Nelson, CFA We’ve all heard the stories. Professional stock pickers can’t beat a bunch of monkeys throwing darts at the pages of the WSJ. A cows’ investment decisions are just as good as the pros’. Stock prices reflect all available information so not even professionals have an edge (e.g. the efficient markets hypothesis). Most professionals can’t outperform their respective benchmarks, so how could mom and pop? Look at this from one of today’s bloggers: The traditional argument, which you’ve probably heard many times before, goes as follows: since most people (even the professionals) can’t … Read more

The Valuentum Weekly Is a Hit! Only Delivered By Email!

by

Image: Excerpt from the November 14 edition of the Valuentum Weekly. November 14, 2021: Inflation Is Positive for Nominal Earnings While Interest Rates Remain at All-Time Lows Tickers mentioned: GOOG, FB, PYPL, DIS, JNJ, BRK.A, BRK.B, ASML, BYND, RIVN, TSLA, JD, WB, BABA, GE, TOSBF, Z, ZG, OPEN, RBLX, GLD November 7, 2021: Large Cap Growth Has More Room to Run Tickers mentioned: SCHG, GME, AMC, BBBY, CVX, XOM, XLE, MA, V, PYPL, QCOM, RSG, NEM, TSLA, PTON, Z, ZG, F, IWN, GMET October 31, 2021: Happy Halloween! Tickers mentioned: AAPL, AMZN, QQQ, SPY, INTC, FB, GOOG, MSFT, LMT, MVRS, DLR, XOM, CVX, DIS, SLB, HON, INTC, CMG, PYPL, PINS, TSLA, HTZZ, PTLO, RSG, SBUX, MCD, NEM, SCHG, IWN October 24, … Read more

Hard Work and the Trust That Binds

by

Image Source: Terry Johnson By Brian Nelson, CFA We’ll have our traditional Valuentum Weekly email coming out on Sunday, and I’m excited to say our team is putting the finishing touches on our technology industry update, so we’ll have a whole bunch of fresh reports for you to look at Sunday evening/Monday morning. It’s easy to forget how much we’ve been through the past two years. Often, we forget how helpful the warning that markets were going to crash was the weekend before they did on February 22, 2020, “Is a Stock Market Crash Coming? – Coronavirus Update and P/E Ratios,” how we thought dollar-cost-averaging made sense at the bottom in March 2020, and how we went “all-in” in April … Read more

Johnson & Johnson Boosts Guidance Again, Posts Great Earnings Update

by

Image Shown: Johnson & Johnson reported strong performance across its three core business operating segments in the third quarter of fiscal 2021. Image Source: Johnson & Johnson – Third Quarter of Fiscal 2021 IR Earnings Presentation By Callum Turcan On October 19, Johnson & Johnson (JNJ) reported third quarter earnings for fiscal 2021 (period ended around the end of September 2021) that missed consensus top-line estimates but beat consensus bottom-line estimates. The healthcare giant also raised its full-year guidance (again) for fiscal 2021 as its ‘Pharmaceutical’ segment is growing at a robust pace, its ‘Medical Device’ segment is steadily recovering from the worst of the coronavirus (‘COVID-19’) pandemic, and its ‘Consumer Health’ segment is holding up well. We continue to … Read more